A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions
Genetically-engineered mouse models (GEMMs) lacking diseased-associated gene(s) globally or in a tissue-specific manner represent an attractive tool with which to assess the efficacy and toxicity of targeted pharmacological inhibitors. and transcription factors have been implicated in several pathop...
Saved in:
Published in | Cancers Vol. 11; no. 9; p. 1226 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
22.08.2019
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Genetically-engineered mouse models (GEMMs) lacking diseased-associated gene(s) globally or in a tissue-specific manner represent an attractive tool with which to assess the efficacy and toxicity of targeted pharmacological inhibitors.
and
transcription factors have been implicated in several pathophysiological conditions, and pharmacological inhibition of both transcription factors has been proposed to treat certain diseases, such as malignancies. To model combined inhibition of
and
we have developed a GEMM harboring a flox
-
allele (
mice) and generated mice lacking
and
in hepatocytes (
).
mice exhibited a marked reduction of STAT3, STAT5A and STAT5B proteins in the liver and developed steatosis, a phenotype that resembles mice lacking
in hepatocytes. In addition, embryonic deletion of
and
(
mice) resulted in lethality, similar to
mice. This data illustrates that
mice are functional and can be used as a valuable tool to model the combined inhibition of
and
in tumorigenesis and other diseases. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2072-6694 2072-6694 |
DOI: | 10.3390/cancers11091226 |